95 related articles for article (PubMed ID: 489521)
1. Insight and adherence to medication in chronic schizophrenics.
Lin IF; Spiga R; Fortsch W
J Clin Psychiatry; 1979 Oct; 40(10):430-2. PubMed ID: 489521
[TBL] [Abstract][Full Text] [Related]
2. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
3. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
6. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
Tsang HW; Fung KM; Corrigan PW
J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
[TBL] [Abstract][Full Text] [Related]
9. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
Misdrahi D; Llorca PM; Lançon C; Bayle FJ
Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
[TBL] [Abstract][Full Text] [Related]
10. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
Kim SW; Yoon JS; Choi SK
Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
[TBL] [Abstract][Full Text] [Related]
11. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders.
Yen CF; Lee Y; Tang TC; Yen JY; Ko CH; Chen CC
J Nerv Ment Dis; 2009 Mar; 197(3):172-7. PubMed ID: 19282683
[TBL] [Abstract][Full Text] [Related]
13. Partial compliance in schizophrenia and the impact on patient outcomes.
Llorca PM
Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
[TBL] [Abstract][Full Text] [Related]
14. A prototype approach toward antipsychotic medication adherence in schizophrenia.
Freudenreich O; Tranulis C
Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
[TBL] [Abstract][Full Text] [Related]
15. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of antipsychotic medication taking in people with schizophrenia.
McCann TV; Deans C; Clark E; Lu S
Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
[TBL] [Abstract][Full Text] [Related]
17. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
18. [Lack of insight in schizophrenia: a review].
Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
Encephale; 2008 Oct; 34(5):511-6. PubMed ID: 19068341
[TBL] [Abstract][Full Text] [Related]
19. [Factors related to treatment adherence in schizophrenic patients].
García Cabeza I; Sánchez Díaz EI; Sanz Amador M; Gutiérrez Rodríguez M; González de Chávez M
Actas Esp Psiquiatr; 1999; 27(4):211-6. PubMed ID: 10469940
[TBL] [Abstract][Full Text] [Related]
20. Enhancing medication use in schizophrenic patients.
Diamond RJ
J Clin Psychiatry; 1983 Jun; 44(6 Pt 2):7-14. PubMed ID: 6133855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
